PRESTRELSKI, Steven,NEWSWANGER, Brett,CUMMINS, Martin,RIDDELL, Mike
申请号：
AU2018388417
公开号：
AU2018388417A1
申请日:
2018.12.21
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
Certain embodiments are directed to methods for treating, ameliorating, or preventing exercise-induced or exercise-associated hypoglycemia comprising administration to a subject in need thereof a formulation(s) of glucagon or glucagon analog in an amount effective to treat, ameliorate, or prevent the condition. The subject can be administered a glucagon or a glucagon analog composition 1, 5, 10, 15 to 20, 25, 30 minutes prior to initiation of exercise.
